Biblio
The combination of the HDC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo. Pharmacol Res. 2023:106926.
. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. J Hematol Oncol. 2023;16(1):9.
. ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells. Blood. 2021.
Association of Fpr1 gene expression with osteogenesis and adipogenesis of adipose derived stem cells. Biochem Biophys Res Commun. 2021;574:33-38.
.